Pavmed Inc (PAVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,251 | -7,972 | -2,825 | -9,519 | -10,389 |
| Depreciation Amortization | 1,124 | 615 | 308 | 355 | 180 |
| Accounts payable and accrued liabilities | 772 | 433 | -97 | -84 | 42 |
| Other Working Capital | 771 | 393 | -529 | 559 | 320 |
| Other Operating Activity | 2,816 | 2,629 | 944 | 2,081 | 4,826 |
| Operating Cash Flow | $-5,769 | $-3,902 | $-2,200 | $-6,608 | $-5,021 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -24 | N/A | N/A | -5 | -5 |
| Investing Cash Flow | $-24 | $N/A | $N/A | $-5 | $-5 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 4,843 | 4,843 |
| Common Stock Issued | 9,231 | 13,847 | 4,409 | 72 | 61 |
| Common Stock Repurchased | N/A | -229 | N/A | N/A | N/A |
| Dividend Paid | -7 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 4,275 | -113 | -113 | 2,648 | 2,648 |
| Financing Cash Flow | $13,499 | $13,505 | $4,296 | $7,563 | $7,552 |
| Beginning Cash Position | 1,535 | 1,535 | 1,535 | 586 | 586 |
| End Cash Position | 9,242 | 11,138 | 3,631 | 1,535 | 3,112 |
| Net Cash Flow | $7,707 | $9,603 | $2,096 | $949 | $2,526 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,769 | -3,902 | -2,200 | -6,608 | -5,021 |
| Capital Expenditure | -24 | N/A | N/A | -5 | -5 |
| Free Cash Flow | -5,792 | -3,902 | -2,200 | -6,614 | -5,026 |